GTI-2501 associated with complete tumor regression in animal models of kidney and breast cancer Nov. 30, 1999 No Comments
Korean farnesyltransferase inhibitor predicted to have favorable PK profile in humans Nov. 30, 1999 No Comments
Isis presents clinical data at AACR-NCI-EORTC meeting; Novartis withdraws from collaboration Nov. 29, 1999 No Comments
Geldanamycin derivative with selective activity against breast cancer developed at Sloan-Kettering Nov. 26, 1999 No Comments